borderline significantp = 0.050
At the 3-month follow-up, a borderline significant reduction compared to baseline was maintained (68.13 ± 41.73 vs 80.63 ± 33.61, p = 0.050) ( Table 2 ).
At the 3-month follow-up, a borderline significant reduction compared to baseline was maintained (68.13 ± 41.73 vs 80.63 ± 33.61, p = 0.050) ( Table 2 ).
However, the difference between the two sessions did not reach statistical significance ( p > 0.05).
Following the second treatment, ISI scores showed a trend of continued decrease, but no statistically significant difference was observed compared to the baseline before the second treatment ( p > 0.05).